can tirzepatide cause low sex drive Are Sexual Side Effects Emerging With GLP-1 Agonists? Tirzepatide: A Game-Changer for Men

[2] State licensure alone does not guarantee formulation quality

Analysis of weight management trials found that only 4.3% of participants permanently discontinued semaglutide 2.4 mg due to gastrointestinal adverse events, with most discontinuations occurring during the dose escalation phase

VDAC: voltage-gated anion channels

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (as Mounjaro) and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities (as Zepbound)